ICU Stock Snapshot
Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ICU Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
×
Reset to default
Apply
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ICU
Peer Median
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ICU
Peer Median
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ICU
Peer Median
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ICU
Peer Median
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
ICU
Peer Median
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ICU
Peer Median
ICU Analyst Consensus
Bullish and bearish analyst opinions, 12-month price target, upside
BUY
5 analysts
Strong Buy
1
20.0%
Buy
3
60.0%
Hold
1
20.0%
Sell
0
0.0%
Strong Sell
0
0.0%
12-Month Price Target
2 analysts
· 2026-08-14
Median
$10.00
← Below all targets
$3.33
Median target
$10.00
+200.3%
Mean target
$10.00
+200.3%
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
Period
EPS Actual
EPS Est
Surprise
June 30, 2026
$-0.91
$-0.98
0.07%
March 31, 2026
$-0.90
$-0.83
-0.07%
Dec. 31, 2025
$-0.80
$-1.07
0.27%
Sept. 30, 2025
$-1.30
$-1.51
0.21%
June 30, 2025
$-1.80
$-4.34
2.5%
March 31, 2025
$-4.40
$-5.25
0.85%
Dec. 31, 2024
$-9.00
$-8.99
-0.01%
Peer comparison (GICS sub-industry)
Key metrics vs sector peers
Ticker
Market Cap
P/E
Rev YoY
Net Margin
ROE
Gross Margin
ICU
—
—
—
—
—
—
NMTC
—
-9.9
163.5%
—
—
—
ADGM
—
-0.7
—
—
—
—
IRIX
$20M
-4.5
8.2%
-8.4%
-80.8%
36.5%
MODD
$25M
-0.4
—
—
-260.0%
—
SINT
$15M
-0.6
-64.7%
-1018.1%
-299.7%
45.3%
CODX
$11M
-0.1
-84.1%
-7533.6%
-151.8%
64.3%
ABT
$250.18B
33.7
5.7%
14.7%
13.1%
—
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
Annual
0
Quarterly
2
Income Statement
15
Quarterly Income Statement data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Revenue ⓘ
2-point trend, +68.9%
$495.0K
$293.0K
+
Cost of Revenue ⓘ
2-point trend, +46000.00
$46.0K
$0
+
Gross Profit ⓘ
2-point trend, +53.2%
$449.0K
$293.0K
+
R&D Expense ⓘ
2-point trend, -3.6%
$2M
$2M
+
SG&A Expense ⓘ
2-point trend, +1.4%
$2M
$2M
+
Operating Expenses ⓘ
2-point trend, -1.5%
$4M
$4M
+
Operating Income ⓘ
2-point trend, +5.7%
$-4M
$-4M
+
Interest Income ⓘ
2-point trend, +89.6%
$91.0K
$48.0K
+
Other Non-op ⓘ
2-point trend, +60.4%
$85.0K
$53.0K
+
Pretax Income ⓘ
2-point trend, +6.7%
$-4M
$-4M
+
Income Tax ⓘ
Flat — no change across 2 periods
$3.0K
$3.0K
+
Net Income ⓘ
2-point trend, +6.7%
$-4M
$-4M
+
EPS (Basic) ⓘ
2-point trend, +79.5%
$-0.90
$-4.38
+
Shares (Basic) ⓘ
2-point trend, +354.7%
3,918,339
861,794
+
EBITDA ⓘ
$-4M
·
Balance Sheet
19
Quarterly Balance Sheet data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Cash & Equivalents ⓘ
$9M
·
+
Receivables ⓘ
$179.0K
·
+
Inventory ⓘ
$57.0K
·
+
Prepaid Expense ⓘ
$1M
·
+
Current Assets ⓘ
$11M
·
+
Other Non-current Assets ⓘ
$499.0K
·
+
Total Assets ⓘ
$11M
·
+
Accounts Payable ⓘ
$719.0K
·
+
Accrued Liabilities ⓘ
$3M
·
+
Short-term Debt ⓘ
$331.0K
·
+
Current Liabilities ⓘ
$4M
·
+
Total Liabilities ⓘ
$4M
·
+
Total Debt ⓘ
$331.0K
·
+
Common Stock ⓘ
$4.0K
·
+
Paid-in Capital ⓘ
$163M
·
+
Retained Earnings ⓘ
$-155M
·
+
Stockholders' Equity ⓘ
$7M
·
+
Liabilities + Equity ⓘ
$11M
·
+
Shares Outstanding ⓘ
3,993,719
·
Cash Flow
6
Quarterly Cash Flow data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Stock-based Comp ⓘ
2-point trend, -45.5%
$91.0K
$167.0K
+
Operating Cash Flow ⓘ
2-point trend, -4.0%
$-3M
$-3M
+
Stock Issued ⓘ
2-point trend, -79.0%
$329.0K
$2M
+
Net Stock Activity ⓘ
$329.0K
·
+
Financing Cash Flow ⓘ
2-point trend, -97.9%
$129.0K
$6M
+
Net Change in Cash ⓘ
2-point trend, -175.7%
$-3M
$3M
Profitability
8
Quarterly Profitability data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Gross Margin ⓘ
90.7%
·
+
Operating Margin ⓘ
-727.9%
·
+
Net Margin ⓘ
-711.3%
·
+
Pretax Margin ⓘ
-710.7%
·
+
EBITDA Margin ⓘ
-727.9%
·
+
ROA ⓘ
-37.3%
·
+
ROE ⓘ
-89.4%
·
+
ROIC ⓘ
-47.2%
·
Liquidity & Solvency
3
Quarterly Liquidity & Solvency data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Current Ratio ⓘ
2.7
·
+
Quick Ratio ⓘ
2.4
·
+
Debt / Equity ⓘ
0.0
·
Efficiency
3
Quarterly Efficiency data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Asset Turnover ⓘ
0.1
·
+
Inventory Turnover ⓘ
0.9
·
+
Receivables Turnover ⓘ
3.4
·
Per Share
3
Quarterly Per Share data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Book Value / Share ⓘ
$1.83
·
+
Cash / Share ⓘ
$2.34
·
+
EPS (TTM) ⓘ
$-2.75
·
Valuation (TTM)
12
Quarterly Valuation (TTM) data for ICU
Metric
Trend
Q1 2026 Q1 2025
+
Revenue TTM ⓘ
$1M
·
+
Net Income TTM ⓘ
$-13M
·
+
Market Cap ⓘ
$15M
·
+
Enterprise Value ⓘ
$6M
·
+
P/E ⓘ
-1.4
·
+
P/S ⓘ
11.3
·
+
P/B ⓘ
2.0
·
+
P / Tangible Book ⓘ
2.0
·
+
P / Cash Flow ⓘ
-5.4
·
+
EV / EBITDA ⓘ
-1.6
·
+
EV / Revenue ⓘ
4.5
·
+
Earnings Yield ⓘ
-73.9%
·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
Latest News
Recent headlines mentioning this company
My Metrics
Your personal watchlist — selected rows from Full Fundamentals
Annual
0
Quarterly
0
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F)
21 filers · $538K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
7
(-5 vs prior Q)
1
(-7 vs prior Q)
2
(+2 vs prior Q)
4
(+2 vs prior Q)
+73K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Institution
Value
Shares
% of tracked 13F
Type
GEODE CAPITAL MANAGEMENT, LLC
$150,243
40,937
27.90%
Shares
VANGUARD CAPITAL MANAGEMENT LLC
$121,444
33,091
22.56%
Shares
UBS Group AG
$115,231
31,398
21.40%
Shares
VANGUARD FIDUCIARY TRUST CO
$50,250
13,692
9.33%
Shares
NORTHERN TRUST CORP
$38,175
10,402
7.09%
Shares
JANE STREET GROUP, LLC
$34,028
9,272
6.32%
Shares
PNC Financial Services Group, Inc.
$18,141
4,943
3.37%
Shares
Tower Research Capital LLC (TRC)
$4,977
1,356
0.92%
Shares
BlackRock, Inc.
$3,351
913
0.62%
Shares
OSAIC HOLDINGS, INC.
$714
195
0.13%
Shares
NewEdge Advisors, LLC
$647
176
0.12%
Shares
Vanguard Global Advisers, LLC
$606
165
0.11%
Shares
VANGUARD GROUP INC
$394
1,642
0.07%
Shares
TD Waterhouse Canada Inc.
$106
22
0.02%
Shares
SBI Securities Co., Ltd.
$51
14
0.01%
Shares
SOA Wealth Advisors, LLC.
$22
6
0.00%
Shares
BARCLAYS PLC
$15
4
0.00%
Shares
HighMark Wealth Management LLC
$7
2
0.00%
Shares
Caitong International Asset Management Co., Ltd
$7
2
0.00%
Shares
MERCER GLOBAL ADVISORS INC /ADV
$4
1
0.00%
Shares
CWM, LLC
$4
1
0.00%
Shares
Company insiders
15 insiders · 4 officers · 10 directors
Insider
Role
Last activity
Shares owned
Buys 12m
Sells 12m
Net 12m
Eric Schlorff
Chief Executive Officer
July 1, 2025
M
98,517
0
0
$0
David A Green
Chief Financial Officer
April 1, 2025
A
10,323
0
0
$0
Caryl Baron
Interim CFO
Nov. 29, 2023
A
139,872
0
0
$0
Kevin Chung
Chief Medical Officer
Aug. 22, 2025
P
58,184
1
0
$8,000
Kenneth Van Heel
Director
Aug. 27, 2025
P
49,400
2
0
$30,850
Jennifer A Baird
Director
July 10, 2025
A
32,000
0
0
$0
Bernadette N Vincent
Director
June 4, 2025
M
12,000
0
0
$0
John Neuman
Director
June 4, 2025
M
92,000
0
0
$0
Allan Collins
Director
Nov. 13, 2024
A
54,343
0
0
$0
Rick Barnett
Director
Nov. 13, 2024
A
86,664
0
0
$0
Andres Lobo
Director
April 12, 2024
A
40,300
0
0
$0
Bruce M. Rodgers
Director
April 12, 2024
A
44,515
0
0
$0
Richard D. Russell
Director
April 12, 2024
A
60,300
0
0
$0
Union Carbide Employees' Pension Plan Trust
10% owner
Oct. 28, 2022
P
2,966,555
0
0
$0
Dow Employees' Pension Plan Trust
10% owner
Oct. 28, 2022
P
4,449,841
0
0
$0
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners
1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
LMFAO Sponsor, LLC, LM Funding America, Inc.
Nov. 7, 2022
—
Initial filing
M&A / sale
SEC
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership
Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
Fund
Weight
Units
As of
Source
VXF
· VANGUARD INDEX FUNDS
0.00%
33,091 SH
Aug. 8, 2026
Daily